Fisher & Paykel Healthcare (FPH) Trading update summary

First half FY26 guidance

• Revenue for the first half of FY26 is expected to be approximately $1.075 billion, with net profit after tax around $200 million, reflecting 13% revenue growth and 31% net profit growth year-on-year.

• Growth outlook is supported by ongoing changes in clinical practice favoring Hospital therapies.

Full year FY26 outlook

• Full year operating revenue is projected between $2.15 billion and $2.25 billion, with net profit after tax between $390 million and $440 million.

• Guidance incorporates a 75-basis point impact from US tariffs on hospital products sourced from New Zealand and assumes current global tariff rates remain unchanged.

Board changes

• Director Pip Greenwood will retire from the board effective 1 September 2025, following her appointment to the Westpac Australia board.

• The process to appoint a new director will commence shortly.